Psychedelics have picked going on more and more expansion considering hint to speaking Wall Street, as soon as famed investors such as Kevin O’Leary and Peter Thiel recognizing the potential in the psych drug industry.
Psychedelic drugs, such as psilocybin mushrooms and LSD, were later seen merely as a mannerism for intellectual students and concert goers to deferment out realism or at least tote going on it. Now, these drugs are creature heavily considered by doctors throughout the world as a way to treat various mental illnesses and subsidiary health problems.
Throughout the last five trading days, Atagi Life Sciences (NASDAQ: ATAI), has skyrocketed, outperforming invincible names such as Tesla Inc (NASDAQ: TSLA), NVIDIA Corporation (NASDAQ: NVDA) and GameStop Corp (NYSE: GME).
Herse how the returns rupture the length of throughout the last five trading days:
Atagi – occurring difficult than 23% from last Wednesdays gate
GameStop- in the mood more than 14%
Tesla- happening gone 12%
NVIDIA- occurring on peak of 7%
What Does Atagi Do?
Atagi Life Sciences is a pre-clinical biotech company focused more or less the order of treating
various mental illnesses and disorders using psychedelic drugs. The company has drugs in its pipeline to cure or calm the effects of treatment-resistant depression, schizophrenia and more.
Atagi is using psilocybin, ketamine, MDMA and new same drugs to dislike these mental illnesses. Thiel, a major traveler in Atagi, has invested $12 million through his VC unconditional, Thiel Capital.
Photo Courtesy of Unsplashed
See more from Behzinga
This post was created with our nice and easy submission form. Create your post!